Back
Biogen Vs. Oracle Industry Stock Comparison
Sell
46
BIIB
Biogen
Last Price:
$135.26
Seasonality Move:
13.83%
Buy
67
ORCL
Oracle
Last Price:
$244.21
Seasonality Move:
7.19%
Sell
46
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ORCL Stock Price Chart
BIIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 48.88 | Sell |
Chaikin Money Flow: | -589526 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (126.84 - 132.72) | Sell |
Bollinger Bands (100): | (120.89 - 134.15) | Buy |
ORCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 68.12 | Buy |
Relative Strength Index (14 RSI): | 63.45 | Buy |
Chaikin Money Flow: | -1811798 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (237.56 - 252.82) | Buy |
Bollinger Bands (100): | (140.58 - 229.06) | Buy |
BIIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 130.22 | Sell |
20-day SMA: | 129.07 | Sell |
50-day SMA: | 129.95 | Sell |
200-day SMA: | 140.01 | Sell |
8-day EMA: | 129.39 | Sell |
20-day EMA: | 129.55 | Sell |
50-day EMA: | 129.4 | Sell |
200-day EMA: | 144.92 | Sell |
ORCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 251.88 | Buy |
20-day SMA: | 248.2 | Buy |
50-day SMA: | 223.76 | Buy |
200-day SMA: | 178.46 | Buy |
8-day EMA: | 236.43 | Buy |
20-day EMA: | 168.21 | Buy |
50-day EMA: | 89.67 | Buy |
200-day EMA: | 26.23 | Buy |
Biogen Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.68 per share, and an increase next year of $0.11 per share.
Oracle Earnings Growth & ORCL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, an increase next quarter of $0.15 per share, an increase this year of $0.41 per share, and an increase next year of $0.79 per share.
Biogen Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Oracle Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |